Annual report [Section 13 and 15(d), not S-K Item 405]

STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.4
STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance (in shares) at Dec. 31, 2022   17,339,816      
Balance at Dec. 31, 2022 $ (13,616) $ 17 $ 1,368,979 $ (153) $ (1,382,459)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (25,091)       (25,091)
Net change in unrealized gain on short-term investments 161     161  
Issuance of common stock upon exercise of options, net of shares withheld, and participation in Purchase Plan (in shares)   99,196      
Issuance of common stock upon exercise of options, net of shares withheld, and participation in Purchase Plan 1,049   1,049    
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares)   43,501      
Stock-based compensation expense 8,853   8,853    
Balance (in shares) at Dec. 31, 2023   17,482,513      
Balance at Dec. 31, 2023 (28,644) $ 17 1,378,881 8 (1,407,550)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 17,485       17,485
Net change in unrealized gain on short-term investments 2     2  
Issuance of common stock upon exercise of options, net of shares withheld, and participation in Purchase Plan (in shares)   158,795      
Issuance of common stock upon exercise of options, net of shares withheld, and participation in Purchase Plan 1,964 $ 1 1,963    
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares)   68,908      
Stock-based compensation expense 12,481   12,481    
Balance (in shares) at Dec. 31, 2024   17,710,216      
Balance at Dec. 31, 2024 3,288 $ 18 1,393,325 10 (1,390,065)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 367,024       367,024
Net change in unrealized gain on short-term investments 171     171  
Issuance of common stock upon exercise of options, net of shares withheld, and participation in Purchase Plan (in shares)   457,027      
Issuance of common stock upon exercise of options, net of shares withheld, and participation in Purchase Plan 8,101   8,101    
Issuance of common stock upon vesting of restricted stock units (RSUs) (in shares)   143,691      
Stock-based compensation expense 12,896   12,896    
Balance (in shares) at Dec. 31, 2025   18,310,934      
Balance at Dec. 31, 2025 $ 391,480 $ 18 $ 1,414,322 $ 181 $ (1,023,041)